Stay updated with breaking news from Raj Malik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to...
- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to Historical Data
RESEARCH TRIANGLE PARK - G1 Therapeutics, Inc. , a commercial-stage oncology company, today announced that G1's Chief Medical Officer Dr. Raj Malik and Chief Commercial Officer Andrew Perry will...
G1 Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.27. G1 Therapeutics, Inc.